Search

Author/Creator McCone, Jonathan

1. Overall safety profile of boceprevir plus peginterferon alfa‐2b and ribavirin in patients with chronic hepatitis C genotype 1: a combined analysis of 3 phase 2/3 clinical trials. (9th October 2013)

Authors:
Manns, Michael P.; McCone, Jonathan; Davis, Mitchell N.; Rossaro, Lorenzo; Schiff, Eugene; Shiffman, Mitchel L.; Bacon, Bruce; Bourliere, Marc; Sulkowski, Mark S.; Bruno, Savino; Balart, Luis; Bronowicki, Jean‐Pierre; Kwo, Paul; Poordad, Fred; Felizarta, Franco; Reddy, K. Rajender; Helmond, Frans...
Journal:
Liver international
Issue:
Volume 34:Number 5(2014:Jun.)
Page Start:
707
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Resistance-Associated Amino Acid Variants Associated with Boceprevir plus Pegylated Interferon-α2B and Ribavirin in Patients with Chronic Hepatitis C in the Sprint-1 Trial. Issue 3 (April 2013)

Authors:
Ogert, Robert A; Howe, John A; Vierling, John M; Kwo, Paul Y; Lawitz, Eric J; McCone, Jonathan; Schiff, Eugene R; Pound, David; Davis, Mitchell N; Gordon, Stuart C; Ravendhran, Natarajan; Rossaro, Lorenzo; Jacobson, Ira M; Ralston, Robert; Chaudhri, Eirum; Qiu, Ping; Pedicone, Lisa D; Brass, Clif...
Journal:
Antiviral therapy
Issue:
Volume 18:Issue 3(2013)
Page Start:
387
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search